Course:

Clinical Trials 1509

Specialty:	Clinical Trial Research	Format:	Text
Course #:	9943	Price:	$15.00
Release date:	2011-09-01	Valid through:	2014-09-01
Publication:	This activity originally appeared in Clinical Trials Administrator (CME).
Course viewing requirements (opens in a new window) Instructions for Course Participation (opens in a new window) Legal disclaimer (opens in a new window)

Target Audience:

This activity is intended for research nurses and physicians.

Sponsor:

This activity is sponsored by AHC Media.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor Melinda Young Executive Editor Michael Harris AHC Media Nurse Planner Elizabeth E. Hill, DNSc, PhD, RN, Associate Chief of Staff for Research VA Sierra Nevada Health Care System Reno, NV Physician Reviewer Raymond Plodkowski, MD Chief of Endocrinology, Diabetes, and Metabolism University of Nevada School of Medicine and Reno Veterans Affairs Medical Center

Subjects:	Technological changes give CR sites more options for running business HHS: expand Common Rule privacy protection Smart phones: calling up apps for new CR uses Tech integration, alliances slow to improve Organization achieves success with EDC system Putting profits to work in CR side of business Here’s expert’s advice to develop a solid budget Site develops incidental findings report model
Objectives:	explain pertinent regulatory mandates develop practical clinical oversight strategies discuss best practices shared by facilities that successfully conduct clinical trials
Financial Disclosure:
Editor Melinda Young, Executive Editor Michael Harris, and Nurse Planner Elizabeth E. Hill, DNSc, PhD, RN, report no consultant, stockholder, speaker's bureaus, research or other financial relationships with companies having ties to this field of study. Physician Reviewer Raymond Plodkowski, MD, has a research affilliation with Orexigen Therapeutics, Abbott Pharmaceuticals, Lilly Pharmaceuticals and GlaxoSmithKline Pharmaceuticals. He is on the speakers bureau of Lilly, Glaxo-SmithKline and Novartis. Copyright 2011 AHC Media. All rights reserved.

You are not currently logged in. To view content articles and complete the post-test for this course, please login or register now